Health Surveillance and Epidemiological Profile of Severe Acute Respiratory Syndrome due to COVID-19 in Brazil (2020-2024)

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

The COVID-19 crisis exposed structural inequalities in Brazil, such as the concentration of healthcare resources in metropolitan areas. Despite the availability of effective vaccines, full immunization coverage was not universal, allowing cases to progress to severe acute respiratory syndrome (SARS). This study aimed to analyze the progression of mild, moderate, and severe cases between January 2020 and December 2024, covering a five-year period, taking into account regional, social, and variant-related differences, vaccination, and factors associated with SARS due to COVID-19 in Brazil. A total of 47,547,814 influenza-like illness (mild and moderate) cases, 2,127,427 SARS cases due to COVID-19, 533,966,291 vaccination records, and data on circulating variants were collected. Among the SARS cases, 1,171,801 were confirmed by PCR; 777,672 patients recovered, and 394,129 died, resulting in a case fatality rate of 33.63%. Brazil experienced three major waves of SARS due to COVID-19, with the second wave being the deadliest across all regions. The Gamma and Omicron variants were the most persistent and impactful. The transition between variants influenced the regional dynamics of the pandemic, although little variation was observed in the proportion of circulating variants across regions. The study highlights the importance of continuous monitoring, genomic surveillance, and vaccination coverage to anticipate and mitigate future pandemic waves.

Article activity feed